Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Adeera Levin; Marcello Tonelli; Joseph Bonventre; Josef Coresh; Jo-Ann Donner; Agnes Fogo; Caroline Fox; Ron Gansevoort; Hiddo Lambers Heerspink; Meg Jardine; Bertram Kasiske; Anna Kottgen; Matthias Kretzler; Andrew Levey; Valerie Luyckx; Ravindra Mehta; Gregorio Obrador; Orson Moe; Neesh Pannu; Chirag Parikh; Vlado Perkovic; Carol Pollock; Peter Stenvinkel; Katherine Tuttle; David Wheeler; Kai-Uwe Eckardt; Dwomoa Adu; Sanjay Agarwal; Mona Alrukhaimi; Hans-Joachim Anders; Gloria Ashuntantang; Shakti Basnet; Aminu Bello; Worawon Chailimpamontree; Ricardo Correa-Rotter; Jonathan Craig; Walter Douthat; H Feldman; Mohammad Ganji; Guillermo Garcia-Garcia; Mohammed Gharbi; David Harris; Vivekanand Jha; David Johnson; Rumeyza Kazancioglu; Robyn Langham; Zhi-hong Liu; Ziad Massy; Masaomi Nangaku; Robert Nelson; Donal O'Donoghue; Ikechi Okpechi; Roberto Pecoits-Filho; Neil Powe; Giuseppe Remuzzi; Charlotte Roberts; Jerome Rossert; Laura Sola; Benedicte Stengel; Ernest Sumaili; Yusuke Suzuki; Tetsuhiro Tanaka; Sajja Tatiyanupanwong; Bernadette Thomas; Katrin Uhlig; Robert Walker; Sarah White; Andrzej Wiecek; Chih-Wei Yang

doi:10.1016/S0140-6736(17)30788-2

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Adeera Levin, Marcello Tonelli, Joseph Bonventre, Josef Coresh, Jo-Ann Donner, Agnes Fogo, Caroline Fox, Ron Gansevoort, Hiddo Lambers Heerspink, Meg Jardine, Bertram Kasiske, Anna Kottgen, Matthias Kretzler, Andrew Levey, Valerie Luyckx, Ravindra Mehta, Gregorio Obrador, Orson Moe, Neesh Pannu, Chirag ParikhVlado Perkovic, Carol Pollock, Peter Stenvinkel, Katherine Tuttle, David Wheeler, Kai-Uwe Eckardt, Dwomoa Adu, Sanjay Agarwal, Mona Alrukhaimi, Hans-Joachim Anders, Gloria Ashuntantang, Shakti Basnet, Aminu Bello, Worawon Chailimpamontree, Ricardo Correa-Rotter, Jonathan Craig, Walter Douthat, H Feldman, Mohammad Ganji, Guillermo Garcia-Garcia, Mohammed Gharbi, David Harris, Vivekanand Jha, David Johnson, Rumeyza Kazancioglu, Robyn Langham, Zhi-hong Liu, Ziad Massy, Masaomi Nangaku, Robert Nelson, Donal O'Donoghue, Ikechi Okpechi, Roberto Pecoits-Filho, Neil Powe, Giuseppe Remuzzi, Charlotte Roberts, Jerome Rossert, Laura Sola, Benedicte Stengel, Ernest Sumaili, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert Walker, Sarah White, Andrzej Wiecek, Chih-Wei Yang

College of Medicine and Public Health

Research output: Contribution to journal › Review article › peer-review

508 Citations (Scopus)

Abstract

The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

Original language	English
Pages (from-to)	1888-1917
Number of pages	30
Journal	Lancet
Volume	390
Issue number	10105
DOIs	https://doi.org/10.1016/S0140-6736(17)30788-2
Publication status	Published - 21 Oct 2017

Access to Document

10.1016/S0140-6736(17)30788-2

Cite this

Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J-A., Fogo, A., Fox, C., Gansevoort, R., Lambers Heerspink, H., Jardine, M., Kasiske, B., Kottgen, A., Kretzler, M., Levey, A., Luyckx, V., Mehta, R., Obrador, G., Moe, O., Pannu, N., ... Yang, C-W. (2017). Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet, 390(10105), 1888-1917. https://doi.org/10.1016/S0140-6736(17)30788-2

@article{1b4047f129e442778c2bd980d3a98367,

title = "Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy",

abstract = "The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.",

author = "Adeera Levin and Marcello Tonelli and Joseph Bonventre and Josef Coresh and Jo-Ann Donner and Agnes Fogo and Caroline Fox and Ron Gansevoort and {Lambers Heerspink}, Hiddo and Meg Jardine and Bertram Kasiske and Anna Kottgen and Matthias Kretzler and Andrew Levey and Valerie Luyckx and Ravindra Mehta and Gregorio Obrador and Orson Moe and Neesh Pannu and Chirag Parikh and Vlado Perkovic and Carol Pollock and Peter Stenvinkel and Katherine Tuttle and David Wheeler and Kai-Uwe Eckardt and Dwomoa Adu and Sanjay Agarwal and Mona Alrukhaimi and Hans-Joachim Anders and Gloria Ashuntantang and Shakti Basnet and Aminu Bello and Worawon Chailimpamontree and Ricardo Correa-Rotter and Jonathan Craig and Walter Douthat and H Feldman and Mohammad Ganji and Guillermo Garcia-Garcia and Mohammed Gharbi and David Harris and Vivekanand Jha and David Johnson and Rumeyza Kazancioglu and Robyn Langham and Zhi-hong Liu and Ziad Massy and Masaomi Nangaku and Robert Nelson and Donal O'Donoghue and Ikechi Okpechi and Roberto Pecoits-Filho and Neil Powe and Giuseppe Remuzzi and Charlotte Roberts and Jerome Rossert and Laura Sola and Benedicte Stengel and Ernest Sumaili and Yusuke Suzuki and Tetsuhiro Tanaka and Sajja Tatiyanupanwong and Bernadette Thomas and Katrin Uhlig and Robert Walker and Sarah White and Andrzej Wiecek and Chih-Wei Yang",

year = "2017",

month = oct,

day = "21",

doi = "10.1016/S0140-6736(17)30788-2",

language = "English",

volume = "390",

pages = "1888--1917",

journal = "Lancet",

issn = "0140-6736",

publisher = "Lancet",

number = "10105",

}

Levin, A, Tonelli, M, Bonventre, J, Coresh, J, Donner, J-A, Fogo, A, Fox, C, Gansevoort, R, Lambers Heerspink, H, Jardine, M, Kasiske, B, Kottgen, A, Kretzler, M, Levey, A, Luyckx, V, Mehta, R, Obrador, G, Moe, O, Pannu, N, Parikh, C, Perkovic, V, Pollock, C, Stenvinkel, P, Tuttle, K, Wheeler, D, Eckardt, K-U, Adu, D, Agarwal, S, Alrukhaimi, M, Anders, H-J, Ashuntantang, G, Basnet, S, Bello, A, Chailimpamontree, W, Correa-Rotter, R, Craig, J, Douthat, W, Feldman, H, Ganji, M, Garcia-Garcia, G, Gharbi, M, Harris, D, Jha, V, Johnson, D, Kazancioglu, R, Langham, R, Liu, Z, Massy, Z, Nangaku, M, Nelson, R, O'Donoghue, D, Okpechi, I, Pecoits-Filho, R, Powe, N, Remuzzi, G, Roberts, C, Rossert, J, Sola, L, Stengel, B, Sumaili, E, Suzuki, Y, Tanaka, T, Tatiyanupanwong, S, Thomas, B, Uhlig, K, Walker, R, White, S, Wiecek, A & Yang, C-W 2017, 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy', Lancet, vol. 390, no. 10105, pp. 1888-1917. https://doi.org/10.1016/S0140-6736(17)30788-2

TY - JOUR

T1 - Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

AU - Levin, Adeera

AU - Tonelli, Marcello

AU - Bonventre, Joseph

AU - Coresh, Josef

AU - Donner, Jo-Ann

AU - Fogo, Agnes

AU - Fox, Caroline

AU - Gansevoort, Ron

AU - Lambers Heerspink, Hiddo

AU - Jardine, Meg

AU - Kasiske, Bertram

AU - Kottgen, Anna

AU - Kretzler, Matthias

AU - Levey, Andrew

AU - Luyckx, Valerie

AU - Mehta, Ravindra

AU - Obrador, Gregorio

AU - Moe, Orson

AU - Pannu, Neesh

AU - Parikh, Chirag

AU - Perkovic, Vlado

AU - Pollock, Carol

AU - Stenvinkel, Peter

AU - Tuttle, Katherine

AU - Wheeler, David

AU - Eckardt, Kai-Uwe

AU - Adu, Dwomoa

AU - Agarwal, Sanjay

AU - Alrukhaimi, Mona

AU - Anders, Hans-Joachim

AU - Ashuntantang, Gloria

AU - Basnet, Shakti

AU - Bello, Aminu

AU - Chailimpamontree, Worawon

AU - Correa-Rotter, Ricardo

AU - Craig, Jonathan

AU - Douthat, Walter

AU - Feldman, H

AU - Ganji, Mohammad

AU - Garcia-Garcia, Guillermo

AU - Gharbi, Mohammed

AU - Harris, David

AU - Jha, Vivekanand

AU - Johnson, David

AU - Kazancioglu, Rumeyza

AU - Langham, Robyn

AU - Liu, Zhi-hong

AU - Massy, Ziad

AU - Nangaku, Masaomi

AU - Nelson, Robert

AU - O'Donoghue, Donal

AU - Okpechi, Ikechi

AU - Pecoits-Filho, Roberto

AU - Powe, Neil

AU - Remuzzi, Giuseppe

AU - Roberts, Charlotte

AU - Rossert, Jerome

AU - Sola, Laura

AU - Stengel, Benedicte

AU - Sumaili, Ernest

AU - Suzuki, Yusuke

AU - Tanaka, Tetsuhiro

AU - Tatiyanupanwong, Sajja

AU - Thomas, Bernadette

AU - Uhlig, Katrin

AU - Walker, Robert

AU - White, Sarah

AU - Wiecek, Andrzej

AU - Yang, Chih-Wei

PY - 2017/10/21

Y1 - 2017/10/21

N2 - The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

AB - The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

UR - http://www.scopus.com/inward/record.url?scp=85018660023&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(17)30788-2

DO - 10.1016/S0140-6736(17)30788-2

M3 - Review article

VL - 390

SP - 1888

EP - 1917

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 10105

ER -

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this